Latest Developments & Updates in Covid-19 Bedside Therapeutics

Talks related to Latest Developments & Updates in Covid-19 Bedside Therapeutics

21

Spatiotemporal analysis of micro-epidemics of influenza and COVID-19

21

SARS-CoV-2 mechanisms of severe outcomes

21

Lung under attack by COVID-19-induced cytokine storm: pathogenic mechanisms and therapeutic implications

21

Baricitinib as a potential drug for COVID-19: evidence from a multicenter trial and translational research studies

21

Allosteric site of SARS-CoV-2 main protease as drug target in the presence of its emerging mutations

22

Stem cells from gestational tissues: a promising tool to restore the body’s own potential to fight SARS-CoV-2 infections

23

The renin angiotensin system (RAS) involvement in SARS-CoV-2 infection

23

Molecular basis of COVID-19 comorbidities

23

Poster Talk: Explainable approach for COVID-19 identification via CT-Scans

24

Vesicular stomatitis virus vectored vaccine for SARS-CoV-2

24

Pulse Therapy with Corticosteroids and Intravenous Immunoglobulin in the Management of Severe COVID-19. Unusual Treatment with Intriguing Results

24

Weighing The Impact of Obesity on COVID-19 in Low- to Middle-Income Countries

24

Poster Talk: The use of Computational Docking to estimate the effects of Montelukast on potential viral main protease catalytic site

25

SARS-CoV-2 Associated Nephropathy in the Pandemic Era

25

Machine learning analysis of single-cell gene regulatory networks reveals potential mechanisms of action of antimalarials against SARS-CoV-2

25

The Clinically Validated Viral Superinfection Therapy (SIT) Platform Technology May Mitigate Severe Cases of COVID-19 Infections